The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 22.50
Bid: 22.00
Ask: 23.00
Change: 0.00 (0.00%)
Spread: 1.00 (4.545%)
Open: 22.50
High: 22.50
Low: 22.50
Prev. Close: 22.50
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ACQUISITION OF INNOVATIONBUBBLE

27 Jul 2020 07:00

RNS Number : 0797U
Mission Group PLC (The)
27 July 2020
 

27 July 2020

 

THE MISSION GROUP plc

("MISSION", "THE GROUP")

 

ACQUISITION OF INNOVATIONBUBBLE

 

MISSION (AIM: TMG), the alternative group for ambitious brands, is pleased to announce the acquisition of Innovationbubble, the international psychological insights and behavioural solutions consultancy.

 

Innovationbubble will sit at the heart of the Group's business model, extending the expertise and capabilities that it provides to its global network of Agencies through the 'MISSION Advantage.' The consultancy provides research and advice to a growing portfolio of clients from blue-chips including Asda, Aviva, HSBC and a number of leading pharmaceutical businesses, to high profile brands such as Diesel and SpaceNK, helping them better understand what drives the behaviour of their customers and ultimately how to improve marketing activity. 

 

James Clifton, Chief Executive of The MISSION Group plc, commented: 

 

"MISSION has a strong track record of integrating earning accretive acquisitions, broadening the Group's range of services, geographic reach and sector expertise. I believe the Covid-19 pandemic will present new opportunities for our business and this acquisition is early testament to our ambitions. 

 

"We are delighted to welcome the Innovationbubble team into MISSION. In the current environment, their unique insight into customer psychology and behaviour is hugely valuable as businesses look to capitalise on the shifting trends we have seen during these unprecedented times. I am confident their expertise will be an important addition to the suite of services we offer our clients through MISSION Advantage and look forward to working with Dr Simon and the team."

 

Dr Simon Moore, CEO of Innovationbubble, said:

 

"MISSION is a fantastic business and the collaborative culture and entrepreneurial spirit which the Group has fostered made them the natural partner for us. 

 

"We are looking forward to becoming part of MISSION and excited to be working with James and the team as the Group continues to build on its impressive growth to date."

 

David Morgan, Chairman of MISSION, added:

 

"In an enormously challenging environment, MISSION has thus far performed remarkably well as a business and the complementary acquisition of Innovationbubble is further testament of the Group's ability to identify opportunities and act decisively."

 

 

CONTACT

 

THE MISSION GROUP PLC

James Clifton, Chief Executive

Peter Fitzwilliam, Chief Financial Officer

Tel: 020 7462 1415

SHORE CAPITAL (Nomad and Broker)

Mark Percy / James Thomas / Sarah Mather

 Tel: 020 7408 4090

 

HOUSTON (Financial PR and Investor Relations)

Kate Hoare / Laura Stewart

Tel: 0203 760 7668

NOTES TO EDITORS

About The MISSION Group PLC

MISSION is a collective of creative Agencies led by like-minded entrepreneurs with an independent spirit. Employing 1,150 people across 31 locations across Europe, Asia and the US, the Group successfully combines the expertise of integrated and specialist Agencies to bring about commercially effective solutions to business challenges for some of the world's biggest Clients. 

With an impressive track record of growth, MISSION has continued to acquire new Agencies with fantastic reputations, expanding its service capability even further.

The group also offers Fuse, a central innovation hub through which it has successfully trialled and developed a number of emerging technologies. Many of these have been grown into successful commercial products that bring value to the MISSION family of Agencies. 

 

www.themission.co.uk

 

ABOUT INNOVATIONBUBBLE

 

Innovationbubble is a specialist group of consumer, business, neuro and behavioural psychologists who, using their extensive commercial experience working with Clients, bring both understanding and interventions in terms of audience engagement.

 

Working across the globe, Innovationbubble has successfully supported businesses in finance, retail, FMCG, travel, technology and healthcare. Employing its unique psychological engines and techniques, Innovationbubble enables clients to work on reality rather than assumption, explaining what its data means from a behavioural point of view and revealing the hidden world of customer and employee decision making. It then works with Client teams to operationalise these scientific insights, utilising their existing understanding of consumers and employees, to make digital, sales and communication outputs more impactful.

 

Innovationbubble has won multiple awards, helping start-ups reach their next level of growth, established brands be leaders in their sector and those in a crowded market differentiate themselves successfully.

 

www.innovationbubble.eu

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAPPUCWMUPUGQC
Date   Source Headline
17th Jun 20227:00 amRNSEBT Share Dealing
16th Jun 20227:00 amRNSEBT Share Dealing
15th Jun 20227:00 amRNSEBT Share Dealing
14th Jun 20227:00 amRNSEBT Share Dealing
13th Jun 20227:00 amRNSEBT Share Dealing
10th Jun 20227:00 amRNSEBT Share Dealing
9th Jun 20227:00 amRNSEBT Share Dealing
1st Jun 20228:46 amRNSEBT Share Dealing
31st May 20227:00 amRNSEBT Share Dealing
24th May 202210:48 amRNSEBT Share Dealing
23rd May 20227:00 amRNSEBT Share Dealing
20th May 20227:00 amRNSEBT Share Dealing
19th May 20227:00 amRNSEBT Share Dealing
18th May 20227:00 amRNSEBT Share Dealing
17th May 20227:00 amRNSEBT Share Dealing
16th May 20227:00 amRNSEBT Share Dealing
12th May 20222:36 pmRNSEBT Share Dealing
20th Apr 20229:04 amRNSDirector Dealing
30th Mar 20227:00 amRNSDividend Timetable
29th Mar 20227:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
28th Feb 20227:00 amRNSACQUISITION OF LIVITY
19th Jan 20227:00 amRNSTrading Update
11th Jan 20227:00 amRNSDirector/PDMR Shareholding
10th Jan 20221:54 pmRNSHolding(s) in Company
5th Jan 202210:07 amRNSHolding(s) in Company
17th Dec 20217:00 amRNSDirectorate Change
29th Nov 202110:16 amRNSHolding(s) in Company
25th Oct 20214:49 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSAcquisition of Soul and Trading Update
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.